30-Second Takeaway
- FH pathogenic variants have similar prevalence across African and European ancestries but may cause larger LDL-C elevations in African ancestry.
- High-penetrance breast cancer P/LP variants associate with non-luminal phenotypes and more frequent mastectomy decisions.
Week ending May 30, 2026
Genetic findings with immediate clinical relevance and areas needing validation
Disclosure of obesity-related SNPs with tailored advice did not change weight overall
In a randomized trial of 53 overweight or obese young adults, providing obesity-related genetic results plus tailored lifestyle advice did not change body weight or composition at 6 or 18 months compared with control. Exploratory subgroup analysis suggested participants carrying ≥2 risk alleles had divergent weight trajectories, with model-adjusted mean changes of +2.68 kg versus −11.58 kg across arms over 18 months. Among intervention-group high-risk carriers, self-reported behavior change associated with modest 6-month weight reductions. This small RCT indicates no overall benefit from disclosure for weight control but suggests possible benefit in a genetically susceptible subset; larger trials are needed.
Genome-first FH study shows similar pathogenic variant prevalence but greater LDL-C and VUS impact in African ancestry
In 104,300 individuals, pathogenic FH variant prevalence was similar in African (1 in 306) and European (1 in 273) ancestry groups. Pathogenic variants produced ~20.8 mg/dL greater LDL-C elevation in African ancestry versus European ancestry. Individuals of African ancestry had higher odds of carrying a VUS (OR 1.61) and VUSs were associated with increased myocardial infarction risk (OR 1.91) only in the African ancestry group. Findings imply current variant-classification resources may underclassify risk in African ancestry and warrant efforts to improve classification and equity.
High-penetrance germline P/LP variants associate with non-luminal tumors and more mastectomies
Among 405 breast cancer patients with germline alterations, high-penetrance P/LP carriers were younger and had higher Ki-67 than other groups. High-penetrance status was independently associated with non-luminal phenotype (adjusted OR 1.79 versus VUS). Triple-negative disease occurred in 33.9% of high-penetrance carriers versus lower rates in other groups. Initial and final mastectomy rates were substantially higher in high-penetrance carriers, informing preoperative counseling and surgical planning.
References
Numbered in order of appearance. Click any reference to view details.
Additional Reads
Optional additional studies from this edition.